Thursday, 16 February, 2017 - 17:47
Board Moves February 16, 2017
Medibio has appointed US-based Jack Cosentino as chief executive and managing director.
Jack Cosentino’s experience includes over 20 years of senior leadership and executive roles in medical device and medical technology companies. Mr Cosentino is chief executive and managing director of Medibio and prior to joining them, Mr Cosentino was chief strategy officer of ASX listed medical device company Impedimed. Other notable roles include 8 years as chief executive of Class IIA medical device company Diversified Medical Corp during which he built the organization from 17 to 320 full-time employees. For over 10 years, Mr Cosentino was co-founder, designing and developing population health platforms that deliver health informatics solutions used globally today. He was senior director, Enterprise Technology Solutions of Medtronic and was responsible for identifying, understanding, and developing enterprise technology solutions to monitor and manage patients across disease states in a variety of patient care environments.
Rank | Company | # | |
---|---|---|---|
1012th | - | TrivarX | $963.76k |
Medibio has appointed US-based Jack Cosentino as chief executive and managing director.
Bevan Tarratt has been appointed an independent non-executive chair of Emergent Resources. He was appointed a non-executive director in 2015 and replaces Edmond Yao who will remain on the board as non-executive director until completion of the company’s acquisition of Prometheus Mining.
Medibio has appointed Jennifer Solitario as senior vice president of corporate health.
Position | Company | Year | Company's current rank |
---|---|---|---|
Chief Executive, Managing Director
|
2017 - 2018 | 1012 |
Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
---|---|---|---|---|---|---|
2017-10-11 | Bought | 10,000,000 | $0.00 | On-market trade | ||
2017-04-18 | Bought | 100,000 | $0.37 | $37,000 | On-market trade | |
2017-04-04 | Bought | 100,000 | $0.37 | $37,000 | On-market trade |